Assessment of ARIA Sufficiency: Myfembree (relugolix, estradiol, and norethindrone acetate)

    Basic Details
    Approval Date
    Wednesday, May 26, 2021
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and neonatal outcomes
    alopecia